头孢地洛（以前为S-649266）是一种新型的儿茶酚取代的肠胃外铁载体头孢菌素，对革兰氏阴性分离株包括多药耐药菌株具有有效的体外抗菌活性。根据CLSIM23-A4质量控制指南的最新研究建立了针对大肠杆菌ATCC25922（0.06-0.5μg/mL）和铜绿假单胞菌ATCC27853（0.06-0.5μg/mL）的头孢地洛MICQC范围。
Cefiderocol (formerly S-649266) is a new catechol-substituted parenteral siderophore cephalosporin with potent in vitro antibacterial activity against Gram-negative isolates including multidrug-resistant strains. A recent
study following CLSI
M23-A4 quality control guidelines established cefiderocol MIC QC ranges against Escherichia coli ATCC 25922 (0.06-0.5 μg/mL) and Pseudomonas aeruginosa ATCC 27853 (0.06-0.5 μg/mL).
PDF(Sci-hub)